Onkure Therapeutics Inc (OKUR)

Apr 04, 2026

Breakouts Watch: Can OnKure Therapeutics Inc deliver consistent EPS growthDay Trade & Free Growth Oriented Trading Recommendations - baoquankhu1.vn

Apr 04, 2026

Apr 04, 2026

OKUR SEC FilingsOnKure Therapeutics 10-K, 10-Q, 8-K Forms - stocktitan.net

Apr 04, 2026

Apr 03, 2026

OnKure (OKUR) CEO Nicholas Saccomano awarded 330,000 stock options - stocktitan.net

Apr 03, 2026

Apr 03, 2026

OnKure (OKUR) CFO granted 110,000 stock options at $4.07 - stocktitan.net

Apr 03, 2026

Apr 03, 2026

OnKure Therapeutics (OKUR) awards 110,000 options to Chief Scientific Officer - stocktitan.net

Apr 03, 2026

Apr 03, 2026

OnKure (OKUR) grants CMO 110,000 stock options at $4.07 strike - stocktitan.net

Apr 03, 2026

Apr 01, 2026

OnKure (OKUR) director receives 15,300 stock options at $4.14 strike price - stocktitan.net

Apr 01, 2026

Apr 01, 2026

OnKure Therapeutics (OKUR) director Liam Ratcliffe submits Form 3 insider report - stocktitan.net

Apr 01, 2026

Apr 01, 2026

Acorn funds and Anders Hove disclose stakes in OnKure (NASDAQ: OKUR) up to 9.5% - stocktitan.net

Apr 01, 2026

Mar 30, 2026

Leerink cuts OnKure stock price target on strategic shift By Investing.com - Investing.com Canada

Mar 30, 2026

Mar 30, 2026

Leerink cuts OnKure stock price target on strategic shift - investing.com

Mar 30, 2026

Mar 30, 2026

OnKure Announces $150M Private Placement and Board Changes - TipRanks

Mar 30, 2026

Mar 30, 2026

OnKure elects Dr. Liam Ratcliffe as director under Lead Investor designation - TradingView

Mar 30, 2026

Mar 30, 2026

OnKure (NASDAQ: OKUR) secures $150M private placement and refocuses PI3Kα pipeline - stocktitan.net

Mar 30, 2026

Mar 29, 2026

Panic Selling: Whats the profit margin of OnKure Therapeutics IncTake Profit & AI Powered Buy and Sell Recommendations - baoquankhu1.vn

Mar 29, 2026

Mar 29, 2026

OnKure Therapeutics Sees Volatile Trading Amid Recent Developments - timothysykes.com

Mar 29, 2026

Mar 28, 2026

OKUR Shares Face Turbulence Amid Financial Downturn - StocksToTrade

Mar 28, 2026

Mar 28, 2026

OnKure Therapeutics Inc. Sees Variable Performance Amid Market Fluctuations - timothysykes.com

Mar 28, 2026

Mar 28, 2026

OnKure to sell $150M in stock to fund drug development - Daily Camera

Mar 28, 2026

Mar 27, 2026

OnKure Therapeutics prices $150M oversubscribed private placement - MSN

Mar 27, 2026

Mar 27, 2026

Oppenheimer reiterates OnKure stock rating on pipeline shift By Investing.com - Investing.com India

Mar 27, 2026

Mar 27, 2026

Oppenheimer reiterates OnKure stock rating on pipeline shift - Investing.com

Mar 27, 2026

Mar 27, 2026

Aug Wrap: Is OnKure Therapeutics Inc in a bullish channelWeekly Investment Recap & Safe Swing Trade Setup Alerts - baoquankhu1.vn

Mar 27, 2026

Mar 27, 2026

OnKure Therapeutics, Inc. announced that it expects to receive $149.999126 million in funding from a group of investors - marketscreener.com

Mar 27, 2026

Mar 27, 2026

OnKure Therapeutics Stock Fluctuates With Market Shifts - StocksToTrade

Mar 27, 2026

Mar 27, 2026

Unprecedented Gains: OKUR Clinches Pivotal Industry Deal - timothysykes.com

Mar 27, 2026

Mar 27, 2026

Onkure Therapeutics to advance next-generation PI3Kα pan-mutant programs - BioWorld MedTech

Mar 27, 2026

Mar 27, 2026

OnKure raises $150M to advance breast cancer programs - Investing.com

Mar 27, 2026

Mar 27, 2026

OnKure raises $150M to advance breast cancer programs By Investing.com - Investing.com UK

Mar 27, 2026

Mar 27, 2026

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Mar 27, 2026

Mar 27, 2026

Onkure Therapeutics Announces Appointment of Liam Ratcliffe to Board of Directors - marketscreener.com

Mar 27, 2026

Mar 25, 2026

OnKure Therapeutics CEO Saccomano sells $357 in stock By Investing.com - Investing.com Australia

Mar 25, 2026

Mar 24, 2026

OnKure Therapeutics, Inc. (NASDAQ:OKUR) Short Interest Down 85.2% in March - marketbeat.com

Mar 24, 2026

Mar 24, 2026

OnKure Therapeutics CFO Leverone sells $1.2k in shares - Investing.com UK

Mar 24, 2026

Mar 24, 2026

OnKure Therapeutics CFO Leverone sells $1.2k in shares By Investing.com - au.investing.com

Mar 24, 2026

Mar 24, 2026

OnKure Therapeutics CEO Saccomano sells $357 in stock - Investing.com

Mar 24, 2026

Mar 24, 2026

OnKure (OKUR) CEO makes small 86-share sale to cover RSU taxes - Stock Titan

Mar 24, 2026

Mar 24, 2026

OnKure Therapeutics (OKUR) CFO sells 301 shares to cover RSU tax withholding - Stock Titan

Mar 24, 2026

Mar 22, 2026

If You Invested $1,000 in OnKure Therapeutics (OKUR) - stocktitan.net

Mar 22, 2026

Mar 19, 2026

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

Mar 19, 2026

Mar 18, 2026

Published on: 2026-03-19 04:03:55 - baoquankhu1.vn

Mar 18, 2026

Mar 18, 2026

OnKure reports nearly $60M cash on hand as drug trials continue - BizWest

Mar 18, 2026

Mar 18, 2026

HC Wainwright Has Positive Forecast for OKUR Q1 Earnings - MarketBeat

Mar 18, 2026

Mar 17, 2026

OnKure Therapeutics (NASDAQ:OKUR) Price Target Lowered to $27.00 at HC Wainwright - Defense World

Mar 17, 2026

Mar 16, 2026

OnKure Therapeutics (OKUR): HC Wainwright & Co. Adjusts Price Ta - GuruFocus

Mar 16, 2026

Mar 16, 2026

H.C. Wainwright cuts OnKure stock price target to $27 on funding By Investing.com - Investing.com South Africa

Mar 16, 2026

Mar 16, 2026

H.C. Wainwright cuts OnKure stock price target to $27 on funding - Investing.com Australia

Mar 16, 2026